These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34382515)

  • 1. Hematological Consequences of Valproic Acid in Pediatric Patients: A Systematic Review with a Mechanistic Approach.
    Riahi-Zanjani B; Delirrad M; Fazeli-Bakhtiyari R; Sadeghi M; Zare-Zardini H; Jafari A; Ghorani-Azam A
    CNS Neurol Disord Drug Targets; 2022; 21(4):316-325. PubMed ID: 34382515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological interaction between valproic acid and carbapenem: what about levels in pediatrics?
    Miranda Herrero MC; Alcaraz Romero AJ; Escudero Vilaplana V; Fernández Lafever SN; Fernández-Llamazares CM; Barredo Valderrama E; Vázquez López M; de Castro P
    Eur J Paediatr Neurol; 2015 Mar; 19(2):155-61. PubMed ID: 25578527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Effects of Treatment with Valproic Acid during the Neonatal Period.
    Baudou E; Benevent J; Montastruc JL; Touati G; Hachon LeCamus C
    Neuropediatrics; 2019 Feb; 50(1):31-40. PubMed ID: 30453358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of valproic acid in children: I. Multiple antiepileptic drug therapy.
    Cloyd JC; Kriel RL; Fischer JH; Sawchuk RJ; Eggerth RM
    Neurology; 1983 Feb; 33(2):185-91. PubMed ID: 6401848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the perturbation of bile acid homeostasis and valproic acid-induced hepatotoxicity.
    Chen Y; Zhou J; Xu S; Liu M; Wang M; Ma Y; Zhao M; Wang Z; Guo Y; Zhao L
    Biochem Pharmacol; 2019 Dec; 170():113669. PubMed ID: 31628911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children.
    Herranz JL; Armijo JA; Arteaga R
    Epilepsia; 1988; 29(6):794-804. PubMed ID: 3142761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures.
    Yu KT; Mills S; Thompson N; Cunanan C
    Epilepsia; 2003 May; 44(5):724-6. PubMed ID: 12752474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of anticonvulsant and toxic potencies of valproic acid and 2-en-valproic acid in different animal models of epilepsy.
    Löscher W; Nau H; Marescaux C; Vergnes M
    Eur J Pharmacol; 1984 Mar; 99(2-3):211-8. PubMed ID: 6428923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of CYP2C9-status guided valproic acid therapy in children.
    Bűdi T; Tóth K; Nagy A; Szever Z; Kiss Á; Temesvári M; Háfra E; Garami M; Tapodi A; Monostory K
    Epilepsia; 2015 Jun; 56(6):849-55. PubMed ID: 25967074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid and thrombocytopenia in children: a case-controlled retrospective study.
    Allarakhia IN; Garofalo EA; Komarynski MA; Robertson PL
    Pediatr Neurol; 1996 May; 14(4):303-7. PubMed ID: 8805173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review.
    Silva MF; Aires CC; Luis PB; Ruiter JP; IJlst L; Duran M; Wanders RJ; Tavares de Almeida I
    J Inherit Metab Dis; 2008 Apr; 31(2):205-16. PubMed ID: 18392741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.
    Coppola G; Auricchio G; Federico R; Carotenuto M; Pascotto A
    Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.
    Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M
    J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child.
    Bromley R; Weston J; Adab N; Greenhalgh J; Sanniti A; McKay AJ; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD010236. PubMed ID: 25354543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the anticonvulsant efficacies and neurotoxic effects of valproic acid, phenytoin, and the ketogenic diet.
    Bough KJ; Eagles DA
    Epilepsia; 2001 Oct; 42(10):1345-53. PubMed ID: 11737171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin U, a novel free radical scavenger, prevents lens injury in rats administered with valproic acid.
    Tunali S; Kahraman S; Yanardag R
    Hum Exp Toxicol; 2015 Sep; 34(9):904-10. PubMed ID: 25504687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between valproic acid response and polymorphisms of its metabolism, transport, and receptor genes in children with focal seizures.
    Feng W; Mei S; Han J; Zhu L; Yu Y; Gao B; Wu Y; Li J; Zhao Z; Fang F
    Neurol Sci; 2019 Mar; 40(3):523-528. PubMed ID: 30564963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children.
    Gerstner T; Buesing D; Longin E; Bendl C; Wenzel D; Scheid B; Goetze G; Macke A; Lippert G; Klostermann W; Mayer G; Augspach-Hofmann R; Fitzek S; Haensch CA; Reuland M; Koenig SA
    Seizure; 2006 Sep; 15(6):443-8. PubMed ID: 16787750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS.
    Nakajima Y; Ito T; Maeda Y; Ichiki S; Kobayashi S; Ando N; Hussein MH; Kurono Y; Sugiyama N; Togari H
    Brain Dev; 2011 Nov; 33(10):816-23. PubMed ID: 21196091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.